DiscoverThe Vox Markets Podcast1999: Q&A with hVIVO’s Mo Khan
1999: Q&A with hVIVO’s Mo Khan

1999: Q&A with hVIVO’s Mo Khan

Update: 2024-12-10
Share

Description


Watch on YouTube



hVIVO #HVO CEO, Yamin 'Mo' Khan announced an £11.5 million contract with an existing top-tier global pharmaceutical client to test an RSV antiviral candidate using hVIVO's Human Challenge Study Model. The Phase 2a trial is set to begin in the second half of 2025 at hVIVO's Canary Wharf quarantine facilities.
Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

1999: Q&A with hVIVO’s Mo Khan

1999: Q&A with hVIVO’s Mo Khan

Vox Markets Podcast